Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, etoricoxib (Arcoxia®) cannot be endorsed for use within NHS Wales for the short-term treatment of moderate pain associated with dental surgery. |
||
|
||
Medicine details |
||
| Medicine name | etoricoxib (Arcoxia®) | |
| Formulation | 30 mg, 60 mg, 90 mg and 120 mg film-coated tablet | |
| Reference number | 981 | |
| Indication | Short-term treatment of moderate pain associated with dental surgery |
|
| Company | Merck Sharp & Dohme Ltd | |
| BNF chapter | Musculoskeletal & joint diseases | |
| Assessment type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 25/10/2012 | |